Thinking of joining a study?

Register your interest

NCT05140642 | Completed | Heart Failure, Systolic


Safety and Efficacy Study of AI LVEF
Sponsor:

Cedars-Sinai Medical Center

Information provided by (Responsible Party):

David Ouyang

Brief Summary:

To determine whether an integrated AI decision support can save time and improve accuracy of assessment of echocardiograms, the investigators are conducting a blinded, randomized controlled study of AI guided measurements of left ventricular ejection fraction compared to sonographer measurements in preliminary readings of echocardiograms.

Condition or disease

Heart Failure, Systolic

Heart Failure, Diastolic

Intervention/treatment

Automated annotation of the left ventricle through deep learning

Sonographer Measurement of LVEF

Phase

Not Applicable

Study Type : Interventional
Estimated Enrollment : 3495 participants
Masking : Single
Masking Description : Measurements shown in Picture Archiving and Communication System (PACS) without direct communication between sonographer and cardiologist. Annotations are shown without identifiers on how the annotations were done. Cardiologists are blinded to source of preliminary interpretation.
Primary Purpose : Diagnostic
Official Title : Blinded Randomized Controlled Trial of Artificial Intelligence Guided Assessment of Cardiac Function
Actual Study Start Date : April 1, 2022
Estimated Primary Completion Date : June 29, 2022
Estimated Study Completion Date : June 29, 2022
Arm Intervention/treatment

Active Comparator: Sonographer Annotation

Currently, sonographer technicians provide preliminary interpretations prior to validation and overreading by cardiologists. This staggered, stepwise evaluation allows for the introduction of AI decision support with minimal impact on patient care. Physicians are already used to adjusting the preliminary report given the variable training of sonographers and on the lookout for changes, variation, or adjustments that need to be made.

Other: Sonographer Measurement of LVEF

Experimental: Artificial Intelligence Annotation

In preliminary work, a novel AI algorithm developed to assess LVEF was shown to be more precise than human interpretation in 10,030 echocardiograms done at Stanford University (Ouyang et al. Nature, 2020). With randomization, a proportion of the preliminary interpretations will be done by AI technology and the study team will assess how different this preliminary interpretation is from the final interpretation.

Other: Automated annotation of the left ventricle through deep learning

Ages Eligible for Study: 18 Years to 110 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No
Criteria
Inclusion Criteria
  • The study imaging studies will include patients who underwent imaging (limited or comprehensive transthoracic echocardiogram studies) and a LVEF was adjudicated in the echocardiography/non-invasive cardiac imaging laboratory.
  • The study participants are cardiologists reading in the echocardiography/non-invasive cardiac imaging laboratory.
Exclusion Criteria
  • The study imaging studies will exclude transesophageal echocardiogram imaging.
  • The study will exclude cardiologists who decline to participate

Safety and Efficacy Study of AI LVEF

Location Details


Please Choose a site



Safety and Efficacy Study of AI LVEF

How to Participate

Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.

Locations


Not yet recruiting

United States, California

Cedars-Sinai Medical Center

The Angels, California, United States, 90048

Loading...